Community FAQs
Frequently asked questions about ANSTO for the community.
Showing 1 - 20 of 44 results
Frequently asked questions about ANSTO for the community.
Five exceptional female science communicators are part of a larger team who use skills in education and engagement to promote an interest in science amongst the public and students.
The 2025 Deaf Youth Science Camp is a chance for Deaf/hard-of-hearing young people (aged 12-17 years old) to participate in an immersive science experience. At the camp, participants will do hands-on science activities, go on tours of different science facilities, and meet Deaf STEM professionals. The camp is also an opportunity to develop personal and leadership skills as well as enhance friendship networks.
Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.
ANSTO provides trusted advice, training and consultancy services to Australia’s resource sector.
Planetary science is an emerging research theme in Australia, and research at ANSTO is embedded in the heart of this.
ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.
General manager ANSTO Communications and Stakeholder Engagement was one of the presenters at the IAEA W4NSEC workshop
The Australian Critical Minerals Research and Development Hub (the Hub) unites the expertise of top Federal science agencies: ANSTO, Geoscience Australia, and CSIRO with the aim of addressing technical challenges and drive collaborative research across the critical minerals value chain.
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
See details of previously published customer updates from our Health products team.
ANSTO’s commitment to Diversity and Inclusion extends to all events we host or conferences we support through sponsorship, expertise (presenting/speaking) or staff attendance as delegates.
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Four international authorities will deliver plenary addresses virtually at the 15th International Conference on Accelerator Mass Spectrometry (AMS15) , which will be held online from 15-19 November.
ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.